Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldesleukin PK in metastatic renal cell carcinoma or melanoma
NCT00414765Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2008
- Primary completion
- Mar 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of aldesleukin in metastatic renal cell carcinoma (mRCC), melanoma, sponsored by Novartis. Started Sep 2008; status: completed.
02
Drugs
aldesleukin
03
Conditions
metastatic renal cell carcinoma (mRCC)melanoma
Beyond the preview
Go deeper on NCT00414765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414765.